Alps Group Inc Stock OTC Markets

ALPS

KYG0231P1081

Healthcare Facilities & Services

Market Closed - OTC Markets 00:00:00 26/09/2026 +04			5-day change	1st Jan Change
0.3960 ^USD	-1.00%		-1.00%	-96.56%

09-03	Can sheep save the glaciers? Swiss scientists put wool to the test	RE
09-01	Alliance Healthcare Bags Mobile Inpatient Care at Home Services Contract	MT

News in other languages: Alps Group Inc

09-03	Suisse: La laine des moutons, une toison d'or pour sauver les glaciers ?
09-03	¿Pueden las ovejas salvar los glaciares? Científicos suizos ponen a prueba la lana
08-31	Sommer 2026: 'Historische Hitze, verbreitete Trockenheit'

More news

Hospitals, Clinics & Primary Care Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALPS GROUP INC	-1.00%	-1.00%	-	-	65.89M
IHH HEALTHCARE	-0.37%	+5.10%	+8.96%	+34.51%	17.42B
APOLLO HOSPITALS ENTERPRISE LIMITED	+0.01%	-0.62%	+16.59%	+74.39%	13.34B
ENCOMPASS HEALTH CORPORATION	+1.20%	+1.41%	-1.69%	+76.23%	12.18B
AIER EYE HOSPITAL GROUP CO., LTD.	-1.25%	-1.62%	-36.16%	-57.03%	10.92B
MANIPAL HEALTH ENTERPRISES LIMITED	-2.02%	-1.55%	-	-	9.98B
THE ENSIGN GROUP, INC.	+1.10%	+0.73%	+3.07%	+86.14%	10.12B
BANGKOK DUSIT MEDICAL SERVICES	+1.00%	+1.51%	-1.94%	-24.49%	9.61B
RAMSAY HEALTH CARE LIMITED	-0.58%	-0.14%	+72.57%	+7.65%	8.94B
PURE HEALTH HOLDING	+1.05%	+7.46%	+0.35%	-	8.71B
Average	-0.09%	+1.36%	+7.72%	+28.20%	11.25B
Weighted average by Cap.	-0.01%	+1.48%	+6.86%	+31.55%

See all sector performances

Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The Company has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The Company provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Companyâ€™s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. It operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
25/09/26	$0.3960	-1.00%	69,697
24/09/26	$0.4000	0.00%	94,533
23/09/26	$0.4000	+0.03%	46,885
22/09/26	$0.3999	-0.03%	61,266
21/09/26	$0.4000	0.00%	66,479

Delayed Quote OTC Markets

More quotes

As early as today, start finding the best investment opportunities!

Market Cap	166M 146M 138M 126M 235M 15.95B 237M 1.65B 639M 8.15B 625M 611M 26.19B	P/E 2024	-226x	P/E 2025	-277x
Enterprise Value	173M 152M 143M 131M 244M 16.57B 246M 1.71B 664M 8.47B 649M 635M 27.21B	EV / Sales 2024	36.6x	EV / Sales 2025	15.2x
Free-Float	27.04%	Yield 2024 *	-	Yield 2025	-

09-03	Can sheep save the glaciers? Swiss scientists put wool to the test	RE
09-01	Alliance Healthcare Bags Mobile Inpatient Care at Home Services Contract	MT
06-23	Alps Group Inc Launches Patient-Derived Organoid Program To Advance Personalized Cancer Care In Southeast Asia	CI
05-20	Alps Group Gets Nasdaq Non-Compliance Notice	MT
04-17	Alps Group Inc Appoints Hee H. Lee as Independent Director, Member of Audit and Compensation Committee, Effective April 17, 2026	CI
02-23	Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol	CI
01-31	Alps Group Inc Announces Potential Expansion Beyond Celesome(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy	CI
01-08	Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer, Effective January 5, 2026	CI
01-08	Alps Group Inc appoints Cheing Lye-Ping as chief financial officer	RE
11-03	Alps Group Inc(NasdaqGM:ALPS) added to NASDAQ Composite Index	CI

08-07	Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update	AQ
06-23	Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia	AQ
06-09	Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022	AQ
05-20	Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency	AQ
04-17	Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight	GL

1 year	0.39	15
3 years	0.39	15
5 years	0.39	15
10 years	0.39	15

	2024	2025
Net sales	2.4M 2.11M 1.99M 1.82M 3.4M 230M 3.42M 23.84M 9.23M 118M 9.02M 8.83M 378M	3.37M 2.96M 2.79M 2.55M 4.77M 323M 4.8M 33.43M 12.95M 165M 12.66M 12.38M 530M
Net income	-2.31M -2.03M -1.92M -1.75M -3.27M -222M -3.29M -22.94M -8.88M -113M -8.68M -8.5M -364M	-2.51M -2.21M -2.08M -1.9M -3.55M -241M -3.58M -24.93M -9.66M -123M -9.44M -9.23M -396M
Net Debt	-1.64M -1.44M -1.36M -1.24M -2.32M -158M -2.34M -16.3M -6.31M -80.47M -6.17M -6.04M -259M	6.49M 5.7M 5.38M 4.9M 9.18M 622M 9.24M 64.38M 24.93M 318M 24.37M 23.84M 1.02B

Alps Group Inc Stock OTC Markets

Stocks

ALPS

KYG0231P1081

Healthcare Facilities & Services

Valuation: Alps Group Inc

Chart: Alps Group Inc

Latest news: Alps Group Inc

Press Releases: Alps Group Inc

News in other languages: Alps Group Inc

Quotes and Performance

Price Extremes

Hospitals, Clinics & Primary Care Services

Financials

Company Profile

Quotes

Markets		Quality
Nasdaq	ALPS	End-of-day quote
OTC Markets	ALPS	Delayed
CBOE	ALPS	Real-time

1 day	-1.00%
Current month	-96.56%
Current year	-96.56%